Get started
Author

Nataly Tarasenko

Observed names: N Tarasenko, N. Tarasenko
OpenAlex ID: A5057100729
Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
2007 · A Rephaeli, S Waks-Yona, et al. · British Journal of Cancer · 45
PDF
The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity
2010 · Nataly Tarasenko, Gania Kessler-Icekson, et al. · Investigational New Drugs · 39
Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)
2008 · Nataly Tarasenko, Abraham Nudelman, et al. · Clinical & Experimental Metastasis · 39
The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties
2007 · Diana Blank-Porat, Tal Gruss-Fischer, et al. · Cancer Letters · 39
In vivo and in vitro antitumor activity of butyroyloxymethyl‐diethyl phosphate (AN‐7), a histone deacetylase inhibitor, in human prostate cancer
2005 · Ada Rephaeli, Diana Blank‐Porat, et al. · International Journal of Cancer · 39
PDF
The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs
2006 · Ada Rephaeli, Michal Entin-Meer, et al. · Investigational New Drugs · 37
Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor
2012 · Nataly Tarasenko, Suzanne M. Cutts, et al. · PLoS ONE · 25
PDF
Novel Prodrugs of Tegafur that Display Improved Anticancer Activity and Antiangiogenic Properties
2007 · Dikla Engel, Abraham Nudelman, et al. · Journal of Medicinal Chemistry · 24
A histone deacetylase inhibitory prodrug – Butyroyloxymethyl diethyl phosphate – Protects the heart and cardiomyocytes against ischemia injury
2012 · G. Kessler-Icekson, E. Hochhauser, et al. · European Journal of Pharmaceutical Sciences · 20
A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo
2014 · Nataly Tarasenko, Suzanne M. Cutts, et al. · Biochemical Pharmacology · 19
Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors
2017 · Nataly Tarasenko, Hanna Chekroun‐Setti, et al. · Journal of Cellular Biochemistry · 17
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair
2017 · Lilach Moyal, Neta Goldfeiz, et al. · Investigational New Drugs · 17
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model
2019 · Mor Dahbash, Ruti Sella, et al. · International Journal of Molecular Sciences · 16
PDF
γ-Aminobutyric Acid Amides of Nortriptyline and Fluoxetine Display Improved Pain Suppressing Activity
2009 · Ada Rephaeli, Irit Gil-Ad, et al. · Journal of Medicinal Chemistry · 16
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin
2016 · Lilach Moyal, Nataly Feldbaum, et al. · PLoS ONE · 13
PDF
Palbociclib in combination with sunitinib exerts a synergistic anti-cancer effect in patient-derived xenograft models of various human cancers types
2022 · Neta Moskovits, Idit Peretz, et al. · Cancer Letters · 10
Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft
2017 · Nataly Tarasenko, Abraham Nudelman, et al. · Investigational New Drugs · 10
Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent manner
2016 · Ada Rephaeli, Nataly Tarasenko, et al. · European Journal of Pharmaceutical Sciences · 6
Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
2022 · Neta Moskovits, Ella Itzhaki, et al. · Journal of Visualized Experiments · 2
Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer
2021 · Nataly Tarasenko, Harel Josef Wilner, et al. · Pharmaceuticals · 2
PDF
AN-446 a Bi-Functional Codrug of the Histone Deacetylase Inhibitor Valproic Acid Linked to the Antiviral Agent Acyclovir as a Targeted Anti-Cancer Agent
2012 · E. Nissim-Bardugo, Michal Weitman, et al. · NSUWorks (Nova Southeastern University)
Abstract 77: The HDAC inhibitory prodrug AN-7 reduces the toxicity of doxorubicin, anti-Her2 and radiation while augmenting their anticancer efficacy
2011 · Nataly Tarasenko, Suzanne M. Cutts, et al. · Cancer Research
Bifunctional Prodrugs of Acyclovir and Histone Deacetylase Inhibitors Selective Affect Epstein-Barr Virus Positive Human Lymphoma Cell Lines
2009 · P. Boer, Carmit Alexenberg, et al. · NSUWorks (Nova Southeastern University)
The grain quality of new winter wheat cultivars.
1970 · Nataly Tarasenko, L. M. Tkacenko, et al. · Selekciâ i semenovodstvo
DNA synthesis in cells of germinating barley and wheat seeds and the effect of chemical mutagens.
1970 · Nataly Tarasenko · Genetika
Works count: 31
Citation count: 435
H-index: 14
I10-index: 17
Year
Topic
Type